Glucagon-like peptide 1 receptor agonists (GLP-1 RAs), also known as incretin mimetics, have many beneficial effects on obesity and inconsistent effects on hepatic enzymes in previous studies [117]. Here, GCG is linked to obesity due to melanocortin 4 receptor deficiency.